Literature DB >> 16224456

Animal models of sepsis: setting the stage.

Jon A Buras1, Bernhard Holzmann, Michail Sitkovsky.   

Abstract

Sepsis is a state of disrupted inflammatory homeostasis that is often initiated by infection. The development and progression of sepsis is multi-factorial, and affects the cardiovascular, immunological and endocrine systems of the body. The complexity of sepsis makes the clinical study of sepsis and sepsis therapeutics difficult. Animal models have been developed in an effort to create reproducible systems for studying sepsis pathogenesis and preliminary testing of potential therapeutic agents. However, demonstrated benefit from a therapeutic agent in animal models has rarely been translated into success in human clinical trials. This review summarizes the common animal sepsis models and highlights how results of recent human clinical trials might affect their use.

Entities:  

Mesh:

Year:  2005        PMID: 16224456     DOI: 10.1038/nrd1854

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  275 in total

1.  Improved methods for thermal rearrangement of alicyclic α-hydroxyimines to α-aminoketones: synthesis of ketamine analogues as antisepsis candidates.

Authors:  Hagit Elhawi; Hadar Eini; Amos Douvdevani; Gerardo Byk
Journal:  Molecules       Date:  2012-06-04       Impact factor: 4.411

2.  The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

Authors:  Chunzhang Cao; Yamei Gao; Yang Li; Toni M Antalis; Francis J Castellino; Li Zhang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

3.  Inhibitory Effect of FXa on Secretory Group IIA Phospholipase A2.

Authors:  Sae-Kwang Ku; Jong-Sup Bae
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

4.  The role of the E2F1 transcription factor in the innate immune response to systemic LPS.

Authors:  Laura A Warg; Judy L Oakes; Rachel Burton; Amanda J Neidermyer; Holly R Rutledge; Steve Groshong; David A Schwartz; Ivana V Yang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-15       Impact factor: 5.464

5.  A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multiple organ injury.

Authors:  Brian D Kubiak; Scott P Albert; Louis A Gatto; Christopher J Vieau; Shreyas K Roy; Kathleen P Snyder; Kristopher G Maier; Gary F Nieman
Journal:  J Surg Res       Date:  2010-11-12       Impact factor: 2.192

6.  Effects of buprenorphine on a cecal ligation and puncture model in C57BL/6 mice.

Authors:  Tara M Cotroneo; Kelly M S Hugunin; Katherine A Shuster; Hae J Hwang; Bala N Kakaraparthi; Jean A Nemzek-Hamlin
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-05       Impact factor: 1.232

7.  The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model.

Authors:  Su Jin Jeong; Beom Jin Lim; Sungha Park; Donghoon Choi; Hye Won Kim; Nam Su Ku; Sang Hoon Han; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Inflamm Res       Date:  2012-07-10       Impact factor: 4.575

8.  Anti-inflammatory effects of hyperoside in human endothelial cells and in mice.

Authors:  Sae-Kwang Ku; Wei Zhou; Wonhwa Lee; Min-Su Han; MinKyun Na; Jong-Sup Bae
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

9.  Orientin inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis.

Authors:  Hayoung Yoo; Sae-Kwang Ku; Taeho Lee; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

10.  A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis.

Authors:  Rui Kang; Ling Zeng; Yangchun Xie; Zhengwen Yan; Borong Zhou; Lizhi Cao; Daniel J Klionsky; Kevin J Tracey; Jianhua Li; Haichao Wang; Timothy R Billiar; Jianxin Jiang; Daolin Tang
Journal:  Autophagy       Date:  2016-10-18       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.